TwinBeech Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
TwinBeech Capital's XENE Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 52,556 shares worth $1.95M. The stake represents 0.46% of the portfolio and ranks #64 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in XENE as recently as Q1 2025.
TwinBeech Capital first reported a position in XENE in Q4 2021 and has held it in 9 quarters since. The position peaked at $4.22M in Q1 2024. 286 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- TwinBeech Capital held 52,556 shares of Xenon Pharmaceuticals worth $1.95M as of Q3 2026.
- Xenon Pharmaceuticals was a new TwinBeech Capital position in Q3 2026.
- Xenon Pharmaceuticals made up 0.46% of TwinBeech Capital's portfolio in Q3 2026, its #64 holding.
- TwinBeech Capital first reported a position in Xenon Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
- TwinBeech Capital's Xenon Pharmaceuticals position peaked at $4.22M in Q1 2024.
- 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.